Why the study?
Do atenolol, verapamil, nifedipine, and carbocromen improve coronary haemodynamics and myocardial oxygen consumption in patients with ischaemic heart disease?
Do atenolol, verapamil, nifedipine, and carbocromen improve coronary haemodynamics and myocardial oxygen consumption in patients with ischaemic heart disease?
Atenolol reduces myocardial oxygen consumption at rest by lowering heart rate, whereas calcium antagonists and carbocromen do not show oxygen-saving effects, with carbocromen potentially inducing coronary steal.
Answers are grounded in this paper and cite their sources.
Atenolol may reduce resting myocardial oxygen consumption via heart rate lowering in ischaemic heart disease; leaves open oxygen-saving effects of calcium antagonists or carbocromen.
Effects on coronary haemodynamics were investigated in patients with ischaemic heart disease. Investigations were performed at rest and during a cardiac stress test provoked by atrial pacing to submaximal heart rates. The effects of 4 drugs used in the treatment of angina pectoris were studied. The continuous infusion thermodilution method was used to measure left ventricular venous drainage. CVF was significantly increased by atrial pacing, both in the GCV and in the CS. Atenolol reduced CVF and MVO 2 at rest, but had no effect during atrial pacing. The decrement in flow and oxygen consumption effected by the drug could be attributed solely to a reduction in heart rate and therefore in left ventricular work. No direct effect on CAR could be identified. Both injection (verapamil) and sublingual (nifedipine) application of calcium antagonists gave a weak coronary vasodilatory effect at rest, but not during cardiac stress. No oxygen saving effect could be demonstrated as both MVO 2 and MVO 2 per unit left ventricular work was totally unaffected by the drugs. Neither was there any effect on the major general haemody‐namic determinants of oxygen demand. Carbocromen was found to be a potent coronary vasodilator both at rest and during atrial pacing. This did not result in any change in MVO 2 as there was a parallel decrease in coronary arteriovenous oxygen difference. Investigations performed during angina pectoris demonstrated metabolic evidence of increased ischaemia after carbocromen which may be due to to a <<coronary steal>> effect. The present study demonstrated that interventions may influence left ventricular oxygen consumtion in a favourable way. On the other hand no effects, or even untoward effects, are exerted by substances which are in use today in patients with coronary heart disease.
No takes yet. Share an insight, caveat, or question.
Svein Simonsen (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: